Biophytis SA (BPTSY)
8.02
-1.40
(-14.86%)
USD |
OTCM |
May 10, 16:00
Biophytis Cash from Operations (TTM): -13.97M for Dec. 31, 2023
Cash from Operations (TTM) Chart
Historical Cash from Operations (TTM) Data
| Date | Value |
|---|---|
| December 31, 2023 | -13.97M |
| June 30, 2023 | -17.87M |
| December 31, 2022 | -19.85M |
| June 30, 2022 | -22.71M |
| December 31, 2021 | -28.04M |
| June 30, 2021 | -28.13M |
| December 31, 2020 | -11.64M |
| Date | Value |
|---|---|
| June 30, 2020 | -4.033M |
| December 31, 2017 | -9.882M |
| June 30, 2017 | -10.32M |
| December 31, 2016 | -7.271M |
| June 30, 2016 | -5.937M |
| December 31, 2015 | -3.614M |
Cash From Operations Definition
Cash flow from operations is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall operating activities of the company. A few examples of operating activities include change in receivables, change in inventories, and changes in current assets.
Cash from Operations (TTM) Range, Past 5 Years
-28.13M
Minimum
Jun 2021
-4.033M
Maximum
Jun 2020
-18.28M
Average
-18.86M
Median
Cash from Operations (TTM) Benchmarks
| Edap TMS SA | -15.89M |
| DBV Technologies SA | -79.65M |
| Cellectis SA | -24.75M |
| Genfit SA | -- |
| Adaptimmune Therapeutics PLC | -140.88M |